AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2024
Jan 3, 2024
34975_dirs_2024-01-03_1e5e3f6e-6deb-4af3-82d4-6cbebab7fc54.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2023-12-29
Reporting Person: Cote Jennifer (Director, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-12-29 | Common Stock | F | 3279 | $5.35 | Disposed | 109689 | Direct |
| 2023-12-29 | Common Stock | F | 2631 | $5.35 | Disposed | 107058 | Direct |
Footnotes
F1: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit awards previously granted to the reporting person that vested in part on December 29, 2023.
F2: Includes (a) 17,928 restricted stock units that will vest in two equal installments on December 29, 2024 and 2025, (b) 11,171 restricted stock units that will vest on December 29, 2024, (c) 25,862 restricted stock units with performance based vesting conditions tied to relative total shareholder return, (d) 29,880 restricted stock units that will vest on March 6, 2024 and (e) 22,217 shares of common stock beneficially owned by the Reporting Person.